Navigation Links
Cancer Medicine Advances on Many Fronts
Date:12/23/2008

as much as 21 percent in patients with non-small cell lung cancer which expressed the epidermal growth factor receptor (EGFR). Patients receiving Erbitux in a recent trial lived an average of 11.3 months vs. 10.1 months in those receiving a placebo. Lung cancer is the number-one cancer killer among men and women; only 5 percent of those diagnosed with this type of lung cancer survive five years.
  • The new chemotherapy drug Gemcitabine (Gemzar) doubled disease-free survival from 6.9 months to 13.4 months in pancreatic cancer patients, and increased overall survival from 20.2 months to 22.8 months in patients with early-stage pancreatic cancer who had undergone surgery. Again, only 5 percent of people receiving this diagnosis live five years.
  • In the area of new drug approvals:

    • Bendamustine (Treanda) "eliminated" chronic lymphocytic leukemia (CLL) in one-third of patients compared with 2 percent who went with current standard therapy, and extended survival without a recurrence to 21.7 months from 9.3 months. The drug was approved in March of 2008 and is now indicated as first-line treatment for the disease.
    • Bevacizumab (Avastin), another monoclonal antibody, was approved (in conjunction with the chemotherapy drug paclitaxel (Taxol) for women with previously untreated HER2-negative, metastatic breast cancer. A trial the year before had found the combination doubled disease-free survival compared with women receiving chemo alone. A second trial, this one from 2008, confirmed the findings.

    In the area of reducing cancer recurrence:

    • Women with breast cancer who have already taken tamoxifen for five years and who take additional hormone therapy in the form of an aromatase inhibitor or more tamoxifen may reduce even further the chances of the cancer coming back.
    • Adding the osteoporosis drug zoledronic acid (Zometa) in premenopausal women with early-stage breast ca
      '/>"/>

    Copyright©2008 ScoutNews,LLC.
    All rights reserved  

    Page: 1 2 3 4

    Related medicine news :

    1. 5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
    2. E. coli engineered to produce important class of antibiotic, anti-cancer drugs
    3. Gene Variant Tied to Smokers Risk of Lung Cancer
    4. Renowned Cancer Researcher Dan Von Hoff, M.D. Advocates for 'The Lost Opportunity in Phase I Oncology Trials'
    5. Holiday Online Auction - Dedicated to Awareness of Male Breast Cancer - Hosted by John W. Nick Foundation, Inc. at MaleBreastCancer.org
    6. Mutations common to cancer and developmental disorder examined in a novel disease model
    7. SNPs of ABC transporter genes linked to lung cancer risk
    8. Gene Boosts Drinkers Colon Cancer Risk
    9. Groundbreaking, inexpensive, pocket-sized ultrasound device can help treat cancer, relieve arthritis
    10. New study shows that a cough medicine ingredient could effectively treat prostate cancer
    11. Marital Distress May Affect Breast Cancer Recovery
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Related Image:
    Cancer Medicine Advances on Many Fronts
    (Date:8/1/2014)... By Kathleen Doheny ... (HealthDay News) -- Birth control pills containing high doses ... the risk of breast cancer in women under 50, ... oral contraceptive formulations," explained lead researcher Elisabeth Beaber, a ... in Seattle. "Some of these formulations increase breast cancer ...
    (Date:8/1/2014)... Roaming the high Alps more than 5,000 years ago, ... Man" no doubt had a very tough and active lifestyle. ... the Ice Man, nicknamed Otzi, from a very modern scourge: ... "hardening of the arteries," appears to be the same today ... finds. "Our ancestors going back thousands of years ...
    (Date:8/1/2014)... The European gas chromatography systems report defines ... forecast of revenue. The gas chromatography systems market in Europe ... to grow to around $247.6 million by 2018, at a ... the TOC of the European gas chromatography systems market, to ... provides a glimpse of the segmentation of gas chromatography systems ...
    (Date:8/1/2014)... to a new market research report of "Thermocouples and ... (Automotive, Petrochemical, Consumer Utility, Glass, and Aerospace & Defense) ... & Forecast to 2010 - 2020", published by MarketsandMarkets, ... Billion by 2020 at a CAGR of 3.70% and ... $238.17 Million by 2020 at a CAGR of 13.81% ...
    (Date:8/1/2014)... The Gerontological Society of America (GSA) ... the field of aging has chosen J. ... 2014 recipient of the Distinguished Career Contribution to ... annually to an individual whose theoretical contributions have ... or have yielded original and elegant research designs ...
    Breaking Medicine News(10 mins):Health News:Some Birth Control Pills May Up Breast Cancer Risk 2Health News:Some Birth Control Pills May Up Breast Cancer Risk 3Health News:'Ice Man' Mummy May Have Been at Risk of Heart Disease 2Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Thermocouples Market worth $1.42 Billion & High End Optical Pyrometers Market worth $ 238.17 Million by 2020 2Health News:Thermocouples Market worth $1.42 Billion & High End Optical Pyrometers Market worth $ 238.17 Million by 2020 3Health News:Thermocouples Market worth $1.42 Billion & High End Optical Pyrometers Market worth $ 238.17 Million by 2020 4Health News:Suitor to receive GSA's 2014 Distinguished Career Contribution to Gerontology Award 2
    ... VIEW, Calif., Nov. 20 Omnicell, Inc. (Nasdaq: OMCL ) a ... company will present at the 21st Annual Piper Jaffray Healthcare Conference ... , Omnicell Speakers: Randall A. Lipps, founder, chairman, president & ... Tuesday, December 1, 2009 , Time: 1:00 p.m. EST , ...
    ... , NEW YORK, Nov. 20 Today, ... announce the launch of a capsule gift giving collection offered exclusively ... is inspired by and designed for St. Jude,s Children,s Research Hospital,s ... program which encourages consumers to "give thanks for the healthy kids ...
    ... DEL REY, Calif., Nov. 20 Heritage Provider Network, and its ... November 6, 2009, Lakeside Medical Systems, Inc., as well as all ... of the HPN family. , "We first and foremost want to ... are dedicated to maintaining the high level of care they are ...
    ... ... the national healthcare network, to deliver multispecialty physicians for locum tenens (temporary substitute) ... ... Healthcare is pleased to announce its agreement with VHA Inc., the national healthcare ...
    ... , NEW ... new market research report is available in its ... Market Review , http://www.reportlinker.com/p0164325/Imaging-Agents---A-Worldwide-Market-Review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ... visualization of organs within the human body. With ...
    ... , Carrying and Lifting Tips to Keep you Injury-free this ... travelers have a saying - " Pack your bags, then take out ... bring much more than we need on our trips. Now, even ... are charging passengers a fee for checking luggage . However, ...
    Cached Medicine News:Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 3Health News:VHA Names Jackson Healthcare as Preferred Physician Staffing Vendor 2Health News:VHA Names Jackson Healthcare as Preferred Physician Staffing Vendor 3Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 2Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 3Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 4Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 5Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 6Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 7Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 8Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 9Health News:This Thanksgiving, Lug your Luggage Safely 2Health News:This Thanksgiving, Lug your Luggage Safely 3
    (Date:7/31/2014)... BURLINGTON, Mass. , July 31, 2014 ... healthcare funding changes brought about by the ... both reimbursement and prescribing of pharmaceutical therapies. ... (MCOs) cover beneficiaries through new regulations and ... is occurring in the health exchanges—state-based marketplaces ...
    (Date:7/31/2014)... Touro University California,s College of Pharmacy is ... recipient of a $150,000 grant by the Joseph & ... increase research and classroom space on its campus. ... study of health sciences, and will help us apply ... of our students," said Shelley Berkley , CEO ...
    (Date:7/31/2014)... -- For its innovative modular Biomedical Research building in ... has earned a Modular Building Institute (MBI) 2014 Award ... categories, MBI,s contest is the commercial modular industry,s premier ... dealers, and product and service providers. ... our team," said Dan Palmer , President of ...
    Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Touro University California Garners Grant From Long Foundation 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4
    ... Data presented today,at the Annual Congress of ... oral Factor Xa inhibitor DU-176b reduced the incidence,of ... elective unilateral hip replacement surgery. There was a,statistically ... the,observed bleeding rates were low across the groups. ...
    ... Bypass Surgery for Safety and ... Condition, WASHINGTON, Sept. 1 Patients with both ... will find good news in,new findings announced today from ... Interventions (SCAI). The one-year findings,of the new study indicate ...
    Cached Medicine Technology:Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b 2SCAI: CARDia Data Find Diabetic Patients With Complex Heart Disease Can Safely Choose PCI 2SCAI: CARDia Data Find Diabetic Patients With Complex Heart Disease Can Safely Choose PCI 3
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: